Merck & Co Inc
NYSE:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Merck & Co Inc
NYSE:MRK
|
US |
|
D
|
D.R. Horton Inc
F:HO2
|
US |
|
J
|
Jastech Ltd
KOSDAQ:090470
|
KR |
|
Lion Copper and Gold Corp
F:QR20
|
CA |
|
A
|
Alaska Air Group Inc
F:ALK
|
US |
|
C
|
Castile Resources Ltd
OTC:CLRSF
|
AU |
|
Kinross Gold Corp
TSX:K
|
CA |
|
Continental AG
OTC:CTTAF
|
DE |
|
FirstRand Ltd
F:FSRA
|
ZA |
|
F
|
Fideicomiso Irrevocable F/3277
BMV:EDUCA18
|
MX |
|
Zug Estates Holding AG
F:ZEE
|
CH |
|
Tractor Supply Co
NASDAQ:TSCO
|
US |
|
S
|
Swiss Re AG
XETRA:SR9
|
CH |
|
O
|
Orica Ltd
OTC:OCLDF
|
AU |
|
C
|
Coherus Oncology Inc
F:8C5
|
US |
|
C
|
Clarity Pharmaceuticals Ltd
OTC:CLRPF
|
AU |
|
P
|
PDF Solutions Inc
F:PD9
|
US |
|
LifeVantage Corp
NASDAQ:LFVN
|
US |
|
Advantest Corp
TSE:6857
|
JP |
|
B
|
BP PLC
DUS:BPE5
|
UK |
|
D
|
Deutsche Telekom AG
SWB:DTEA
|
DE |
|
Renew Holdings PLC
F:LLP
|
UK |
|
P
|
Planktos Corp
OTC:PLKT
|
US |
|
Sofina SA
XBRU:SOF
|
BE |
Bankruptcy Probability
Merck & Co Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Merck & Co Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Merck & Co Inc
NYSE:MRK
|
350.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
647.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
506.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
378.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
244B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
197.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
169.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Merck & Co Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Merck & Co Inc has total debt of 51.1B USD. This includes both short-term (0 USD) and long-term (51.1B USD) debt.
You can find a full breakdown on its Balance Sheet.